ATF6 upregulates XBP1S and inhibits ER stress-mediated apoptosis in osteoarthritis cartilage

Cell Signal. 2014 Feb;26(2):332-42. doi: 10.1016/j.cellsig.2013.11.018. Epub 2013 Nov 21.

Abstract

As we previously reported, transcription factor XBP1S enhances BMP2-induced chondrocyte differentiation and acts as a positive mediator of chondrocyte hypertrophy. The purpose of this study was to determine (1) whether XBP1S influences ER stress-mediated apoptosis in osteoarthritis (OA); (2) whether ATF6 regulates IRE1/XBP1 signal pathway in OA cartilage; (3) what are the associated molecules affecting apoptosis in osteoarthritis and the molecular events underlying this process. Herein, we examined and found that ER stress-associated molecules were activated in OA patients, specifically XBP1S splice and expression were increased markedly by TNF-α and IL-1β treatments. Transcription factor ATF6 can specifically bind to the promoter of XBP1 gene and enhance the expression of XBP1S spliced by IRE1α in osteoarthritis cartilage. Furthermore, siXBP1S can enhance ER stress-mediated apoptosis and main matrix degradation in osteoarthritis. Whereas AdXBP1S can inhibit ER stress-mediated apoptosis and TNFα induced nitrite production in OA cartilage. In a word, our observations demonstrate the importance of XBP1S in osteoarthritis. ATF6 and IRE1α can regulate endogenous XBP1S gene expression synergistically in OA cartilage. More significantly, XBP1S was a negative regulator of apoptosis in osteoarthritis by affecting caspase 3, caspase 9, caspase 12, p-JNK1, and CHOP.

Keywords: ATF6; Apoptosis; BMP2; Cartilage; ER; ER stress response element; ERSE; Endoplasmic reticulum stress; IRE1; OA; Osteoarthritis; PERK; PKR-like ER resistant kinase; UPR; X-box binding protein 1 spliced form; XBP1S; activating transcription factor 6; bone morphogenetic protein 2; endoplasmic reticulum; inositol requiring enzyme 1; osteoarthritis; unfolded protein response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 6 / antagonists & inhibitors
  • Activating Transcription Factor 6 / genetics
  • Activating Transcription Factor 6 / metabolism*
  • Aged
  • Apoptosis* / drug effects
  • Cartilage / drug effects
  • Cartilage / metabolism
  • Cartilage / physiopathology*
  • Cell Line
  • DNA-Binding Proteins / antagonists & inhibitors
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Endoplasmic Reticulum Stress* / drug effects
  • Endoribonucleases / antagonists & inhibitors
  • Endoribonucleases / genetics
  • Endoribonucleases / metabolism
  • Humans
  • Interleukin-1beta / pharmacology
  • Middle Aged
  • Osteoarthritis / metabolism
  • Osteoarthritis / physiopathology*
  • Promoter Regions, Genetic
  • Protein Binding
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • RNA, Small Interfering / metabolism
  • Regulatory Factor X Transcription Factors
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / genetics*
  • Transcription Factors / metabolism
  • Transcriptional Activation / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation / drug effects
  • Up-Regulation / genetics
  • X-Box Binding Protein 1

Substances

  • Activating Transcription Factor 6
  • DNA-Binding Proteins
  • Interleukin-1beta
  • RNA, Small Interfering
  • Regulatory Factor X Transcription Factors
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • X-Box Binding Protein 1
  • XBP1 protein, human
  • ERN1 protein, human
  • Protein Serine-Threonine Kinases
  • Endoribonucleases